647 results on '"Dressler, D."'
Search Results
2. Therapieziele bei Patienten mit Armspastik nach Schlaganfall nach Injektion mit Botulinumtoxin A: Ergebnisse der deutsch-österreichischen Subgruppe der ULIS-II-Studie
3. Impaired heart rate variability in cervical dystonia is associated to depression
4. Intrathecal Baclofen therapy in Germany: Proceedings of the IAB—Interdisciplinary Working Group for Movement Disorders Consensus Meeting
5. Albert Schweitzer: A patient with writer’s cramp
6. Botulinum toxin drugs: brief history and outlook
7. Slow pre-movement cortical potentials do not reflect individual response to therapy in writer’s cramp
8. Integrated plasma processing simulation framework, linking tool scale plasma models with 2D feature scale etch simulator
9. Detecting Alzheimer's Disease
10. Pharmakologie der Botulinumtoxinmedikamente
11. EP07.04-10 Early-Stage EGFR Mutated NSCLC: Outcomes After Surgical Resection at a Large Academic Medical Center
12. EP06.03-11 Characterization of KRAS Mutations in Black Patients with NSCLC at an Urban Academic Medical Center
13. New method for the precise flux calculation of neutrals for arbitrary surfaces in profile etch simulations
14. Reversal learning in writerʼs cramp is not altered and induces normal associated neural activity: 1428
15. Tele-rehabilitation to improve botulinum toxin therapy: 1420
16. Safety aspects of high-dose incobotulinumtoxinA therapy: 834
17. The dystonia discomfort scale (DDS): A self-assessment scale for monitoring the temporal profile of botulinum toxin therapy in dystonia: 475
18. The Dystonia Discomfort Scale (DDS): a novel instrument to monitor the temporal profile of botulinum toxin therapy in cervical dystonia
19. Sonographic detection of basal ganglia abnormalities in spasmodic dysphonia
20. Intermittierende Apomorphin-Injektionen als Rescue-Therapie beim fortgeschrittenen M. Parkinson: Konsensusstatement
21. Pharmakologische Aspekte therapeutischer Botulinum-Toxin-Präparationen
22. Sonographic discrimination of dementia with Lewy bodies and Parkinson's disease with dementia
23. Diagnosis and management of acute movement disorders
24. Botulinum toxin type B de novo therapy of cervical dystonia: Frequency of antibody induced therapy failure
25. Botulismus durch Räucherlachsverzehr
26. Apomorphin bei der Behandlung des Morbus Parkinson
27. Der Einsatz von Botulinumtoxin in der Therapie von Muskelschmerzen
28. Antikörpervermitteltes Versagen der Botulinum-Toxin-Therapie
29. Botulinum toxin therapy in the presence of anticoagulation: Hematoma frequency
30. An enzyme-linked immunosorbent assay for detection of botulinum toxin antibodies
31. Antigenicity of botulinum toxin drugs
32. Botulinumtoxin – Die Dosis macht das GiftEin historischer Abriss: Ein historischer Abriss
33. Erste Erfahrungen mit der klinischen Anwendung von Botulinum-Toxin Typ B
34. Substantia nigra echogenicity is normal in non-extrapyramidal cerebral disorders but increased in Parkinson's disease
35. Five-year experience with incobotulinumtoxinA (Xeomin®): the first botulinum toxin drug free of complexing proteins
36. PP01.73 Time from Biopsy to Treatment Initiation at an Academic Hospital and Affiliate Hospitals: Overall Survival Analysis
37. PP01.49 Analysis of Outcomes by Race in Patients with Advanced NSCLC
38. Botulinum toxin for treatment of dystonia
39. On muscle spindles, dystonia and botulinum toxin
40. Botulinum toxin drugs: future developments
41. Routine use of Xeomin® in patients previously treated with Botox®: long term results
42. Entwicklungsperspektiven von Botulinum-Toxin-Medikamenten
43. Spasmodic laryngeal dyspnea: a rare manifestation of laryngeal dystonia
44. Botulinumtoxintherapie in der Rehabilitationsneurologie
45. New formulation of Botox: complete antibody-induced treatment failure in cervical dystonia
46. Overactive bladder in Parkinsonʼs disease: alteration of brainstem raphe detected by transcranial sonography
47. Botulinum toxin therapy of writerʼs cramp
48. Botulinum toxin therapy of hemifacial spasm: comparing different therapeutic preparations
49. Immunological aspects of Botox®, Dysport® and Myobloc™/NeuroBloc®
50. Pharmacology of botulinum toxin: differences between type A preparations
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.